Cargando…

Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy

PURPOSE OF REVIEW: Diabetic nephropathy (DN) is a progressive kidney disease caused by alterations in kidney architecture and function, and constitutes one of the leading causes of end-stage renal disease (ESRD). The purpose of this review is to summarize the state of the art of the DN-biomarker fie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campion, Carole G., Sanchez-Ferras, Oraly, Batchu, Sri N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Narrative Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461910/ https://www.ncbi.nlm.nih.gov/pubmed/28616250 http://dx.doi.org/10.1177/2054358117705371

Ejemplares similares

Bridging Gaps in Diabetic Nephropathy Care: A Narrative Review Guided by the Lived Experiences of Patient Partners
por: Beaubien-Souligny, William, et al.
Publicado: (2022)

The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes
por: Zhang, Deyuan, et al.
Publicado: (2019)

CKD of Unknown Origin in Central America: The Case for a Mesoamerican Nephropathy
por: Correa-Rotter, Ricardo, et al.
Publicado: (2014)

Eosinophil: An innate immune cell with anti‐filarial vaccine and biomarker potential
por: Kwarteng, Alexander, et al.
Publicado: (2023)

Reducing unnecessary urinary catheter use and other strategies to prevent catheter-associated urinary tract infection: an integrative review
por: Meddings, Jennifer, et al.
Publicado: (2014)

A coordinated progression of progenitor cell states initiates urinary tract development
por: Sanchez-Ferras, Oraly, et al.
Publicado: (2021)

Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy
por: Han, Qiuxia, et al.
Publicado: (2021)

Urinary angiotensinogen as a potential biomarker of diabetic nephropathy
por: Satirapoj, Bancha, et al.
Publicado: (2014)

Myocardial Infarction in Iran: Epidemiology, Management, and Prognosis
por: Beyranvand, Mohammad Reza, et al.
Publicado: (2023)

Beyond diagnosis: is there a role for radiomics in prostate cancer management?
por: Stanzione, Arnaldo, et al.
Publicado: (2023)

Dance/Movement Therapy and the Arts in Healthcare: The First 50 Years
por: Goodill, Sherry W.
Publicado: (2016)

Perspective from a Patient Partner
por: Gaetz, Lyn
Publicado: (2020)

How COVID-19 Is Testing and Evolving Our Communication Skills
por: Julka-Anderson, Naman
Publicado: (2020)

Learning to Work Together—a BRIDGE to Engagement
por: Houlihan, Mary Ellen
Publicado: (2021)

An End-User’s Personal Perspective on the Need of Consumer Involvement in Research
por: Ferry, S. M., et al.
Publicado: (2022)

“Not all groups come together, but this one just clicks”: Ten Tips for Sustaining an Engagement Panel
por: Jensen, Agnes C., et al.
Publicado: (2022)

A Sample of the Future: Digital Health and Near-Patient Testing
por: Grys, Thomas E., et al.
Publicado: (2023)

Brain injury after cardiac arrest: pathophysiology, treatment, and prognosis
por: Sandroni, Claudio, et al.
Publicado: (2021)

New Biomarkers for Cardiovascular Disease
por: Kim, Stephanie J., et al.
Publicado: (2023)

What do Cochrane systematic reviews say about non-surgical interventions for urinary incontinence in women?
por: da Costa, Anderson Adriano Leal Freitas, et al.
Publicado: (2018)

Potential Role of N-Cadherin in Diagnosis and Prognosis of Diabetic Nephropathy
por: Ali, Hamad, et al.
Publicado: (2022)

Mobile Health for Arrhythmia Diagnosis and Management
por: Baman, Jayson R., et al.
Publicado: (2021)

Can adjuvant chemotherapy improve the prognosis of adult ovarian granulosa cell tumors?: A narrative review
por: Zhuang, Yuan, et al.
Publicado: (2022)

How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
por: Póvoa, Pedro, et al.
Publicado: (2023)

Ovarian cancer beyond imaging: integration of AI and multiomics biomarkers
por: Hatamikia, Sepideh, et al.
Publicado: (2023)

Comparison of recent updates in genetics, immunology, biomarkers, and neuroimaging of primary‐progressive and relapsing‐remitting multiple sclerosis and the role of ocrelizumab in the management of their refractory cases
por: Prajjwal, Priyadarshi, et al.
Publicado: (2023)

The potential role of telemedicine in the infectious disease pandemic with an emphasis on COVID‐19: A narrative review
por: Shokri, Fazlollah, et al.
Publicado: (2023)

Effectiveness of COVID-19 diagnosis and management tools: A review
por: Alsharif, W., et al.
Publicado: (2021)

Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review
por: McFarlane, Philip A., et al.
Publicado: (2021)

The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs
por: Palmnäs-Bédard, Marie S A, et al.
Publicado: (2022)

Tumor lysis syndrome in gynecologic cancers: An uncommon but important diagnosis to recognize
por: Castellano, T., et al.
Publicado: (2019)

Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease
por: Tangri, Navdeep, et al.
Publicado: (2017)

Comparison of Published Guidelines for the Diagnosis and the Management of Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Zazzeron, Luca, et al.
Publicado: (2021)

Transform diabetes care with precision medicine
por: Kannan, Sharumathy, et al.
Publicado: (2023)

Prevention of Type 1 Diabetes: Current Perspective
por: Pande, Arun K., et al.
Publicado: (2023)

Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy
por: Gluhovschi, Cristina, et al.
Publicado: (2016)

Glycopatterns of Urinary Protein as New Potential Diagnosis Indicators for Diabetic Nephropathy
por: Zhu, Hanyu, et al.
Publicado: (2017)

Big data and machine learning to tackle diabetes management
por: Pina, Ana F., et al.
Publicado: (2022)

Vitamin C and its therapeutic potential in the management of COVID19
por: RS, Neethu, et al.
Publicado: (2022)

Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
por: Zürbig, Petra, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_r37bde56ei3g4ttnmb93kpl61o